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A heterologous indirect competitive enzyme linked immuno sorbent assay (icELISA) has been developed 
for the determination of enrofloxacin (ENR) residues in poultry. For this purpose, carbodiimide active 
ester method was employed to synthesize the artificial antigen of ENR- bovine serum albumin (BSA) 
while mixed-anhydride technique was used to synthesize the coating antigen of ENR- ovalbumin (OVA), 
to pursue the heterologous sensitivity. By square matrix titration, an icELISA method was developed, 
and the linear range was from 0.02 to 86.3 ng/mL, with limit of detection (LOD) and IC50 value of 0.8 and 
0.01 ng/mL, respectively. After optimization, 5% of NaOH was used in the assay buffer and this ELISA 
system can tolerate methanol not higher than 30%. The correlation coefficients (R
2
) between 
concentration spiked and concentration determined were 0.9975 in chicken muscle and 0.9959 in duck 
muscle, respectively. Therefore, this assay has the potential to be incorporated into a quantitative 
monitoring program for the rapid screening of ENR residue in poultry muscles. 
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Enrofloxacin (ENR) is the first specific fluoroquinolone 
developed for veterinary application, which belongs to the 
second generation of quinolone antibiotics fluorinated in 
position 6 and bearing a piperazinyl moiety in position 7. 
Similar to other fluoroquinolones, enrofloxacin is used in 
the treatment of systemic infections including urinary 
tract, respiratory, gastro-intestinal and skin infections 
(Tong et al., 2010). Due to the very broad spectrum of 
activity against both gram-negative and gram-positive 
bacteria and lower side effects, ENR has also been widely 
used for the treatment of some infectious diseases in  
pets   and   livestock.   However,  ENR  residues  may 
persist in animal body and may result in the development 
of drug-resistant bacterial strains or allergies. In the 
present years, awareness of residual antibiotics in animal-
derived food is growing as their application increases in 
both human and veterinary medicine (Yan et al., 2011). 
In order to monitor enrofloxacin residue levels in 
livestock and poultry products, simple and rapid analytical 
methods are required. Various analytical methods, such 
as high performance liquid chromatography (HPLC) 
(Christodoulou et al., 2008), liquid chromatography-mass 
spectrometry (LC-MS) (Delepine et al., 1998; San Martin 
et   al.,   2007),  and  LC-MS/MS  (Dufresne  et  al.,  2007; 
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Hermo et al., 2008) have been reported. However, many 
of the instrumental methods used to monitor the residues 
are time-consuming, solvent intensive, and costly; 
therefore, chromatographic and mass spectrometry 
methods are not practical for screening large numbers of 
food samples for ENR. The enzyme-linked 
immunosorbent assay (ELISA) was widely employed 
because of its sensitivity of detection and ease of use. 
Several papers have reported the development of an 
immunoassay for the determination of ENR residue 
(Watanabe et al., 2002; Wang et al., 2007; Zhang et al., 
2011). However, there have not yet any reports of 
preparation a rabbit polyclonal antibody (pAb) for ENR 
and development of a heterologous immunoassay. In this 
study, we aimed to prepare the artificial antigen of ENR 
and produce anti-ENR pAb. We have also developed an 
indirect competitive heterologous immunoassay for 
monitoring enrofloxacin residues in poultry muscles. 
 
 
MATERIALS AND METHODS 
 
Materials and equipment 
 
Enrofloxacin, ciprofloxacin and other fluoroquinolones (FQs) were 
provided by Sigma (St. Louis, MO). 1-ethyl-3-(3-
dimethylaminopropyl) (EDC), freund's complete adjuvant (FCA) and 
freund's incomplete adjuvant (FIA) were obtained from Pierce while 
N-hydroxysuccinimide (NHS) was from Japan; MSDS available. O-
(Carboxymethyl) hydroxylamine hemihydrochloride, succinic 
anhydride, bovine serum albumin (BSA) and ovalbumin (OVA) were 
supplied by Sigma while Dialysis bag (8000-14000 Da) was from 
Solarbio company. The peroxidase-conjugated rabbit anti-mouse 
IgG (GaRIgG-HRP) was purchased from Sino-American 
Biotechnology Company (Shanghai, China). 3,3,5,5-
tetramethylbenzidine (TMB), phenacetin, urea peroxide were 
obtained from Sigma Company. All other solvents and reagents 
were of analytical grade or higher, unless otherwise stated. A 
spectrophotometric microtitre reader, Multiskan MK3 (Thermo 
company, USA), provided with a 450 nm filter, was used for 
absorbance measurements. Fresh meat samples of poultry 
(chicken tissue and duck) were purchased in retail outlets in 
Xinxiang, China. Female New Zealand white rabbits weighing 2–2.5 
kg were obtained from the Laboratory Animal Center, Beijing 
Medical University, China, and raised under strictly controlled 
conditions in our laboratory chamber. 
Synthesis of immunogen and coating antigen 
 
The immunogen of ENR-BSA was prepared by carbodiimide active 
ester method. Briefly, a total of 4.18 mg of ENR, 20.64 mg of EDC, 
and 5.76 mg of NHS were added to 2 mL dimethylformamide (DMF) 
respectively. The mixture solution was incubated for 24 h at room 
temperature in dark. Then 2.5 mL of phosphate buffer saline (PBS) 
(0.01 mol/L, pH 7.4) with 26.4 mg BSA was added slowly to the 
mixture solution with stirring, followed by 4 h incubation at room 
temperature. The synthesis procedure is shown in Figure 1. Finally, 
the reaction mixture was dialyzed under stirring against PBS for 6 
days with repeated changes of the PBS solution to remove the 
unconjugated hapten. The solution was stored at -20°C.  An ENR-
OVA conjugate was prepared as a modified previous paper (Huang 
et al., 2010) and the mixed-anhydride technique route was as 
shown in Figure 2. 
 
 
Polyclonal antibody generation 
 
Two female New Zealand white rabbits were subcutaneously 
immunized at multiple sites in the back with ENR-BSA conjugate, 
and under control of the local Ethical Committee for Research. The 
initial immunization was injected with 500 μg of conjugate in 0.5 mL 
of PBS and 0.5 mL of FCA. Subsequent 4 booster injections (0.5 
mg of conjugate in 0.5 mL of PBS plus 0.5 mL of FIA) were 
performed three weeks later and then at 15 days intervals. Ten 
days after the last boost, all rabbits were exsanguinated by heart 
puncture under general anesthetic. The antiserum was prepared by 
allowing the blood to clot overnight at 4°C, followed by 
centrifugation at 10000 r/min for 20 min to remove particulate 
materials. The crude serum was purified by saturated ammonium 
sulfate (SAS) precipitation method (purified three times using SAS). 
The purified serum was then aliquotted and stored at -70°C. 
 
 
Development of a heterologous icELISA 
 
The checkerboard procedure was used to optimize the coating 
antigen and the primary antibody concentrations, resulting in the 
following optimized protocol. To each well of a 96 well plate, 100 μL 
of selected coating antigen was added and incubated for 2 h at 
37°C. The plate was washed three times with PBST (PBS 
containing 0.05% Tween-20) and blocked with 250 μL/well of 
blocking buffer, followed by incubation for 1 h at 37°C. After another 
washing procedure, varying  concentrations  of  ENR or competitive 
fluoroquinolones (50 μL/well) was added, followed by equal volume 
of ENR antiserum previously diluted 10, 000 folds in PBS according 
to the optimal data. The following steps were similar to the indirect 
ELISA (Jiang et al., 2011). Absorbances  were  corrected  by  blank 
 
 































reading and the results were expressed in percent inhibition rate. 
Sensitivity was evaluated according to the inhibition rate, and the 
data were calculated using the IC50 values, which represented the 
concentration of ENR that produced 50% inhibition of antiserum 
binding to the hapten conjugate. The limit of detection (LOD) was 
defined as the lowest concentration that exhibits a signal of 15% 
inhibition (Jiang and Wang, 2011). The dynamic range for the 
icELISA was calculated as the concentration of the analyte 
providing a 20–80% inhibition rate (IC20–IC80 values) of the 
maximum signal. Specificity was defined as the ability of structurally 
related chemicals to bind to the specific antibody. The cross-
reactivity was calculated as: (IC50 of ENR)/ (IC50 of competitors) 
×100. The lower the CR, the higher the specificity of ENR pAb (Lei 
et al., 2010). 
 
 
Chemical effects on assay performance 
 
It is commonly acknowledged that immunoassay performance is 
often affected by chemical parameters such as ionic strength, pH 
values, organic solvent concentration, and other substances in the 
sample matrix. The effects of these parameters were estimated by 
the maximum absorbance (Amax, the absorbance value at zero 
concentration of ENR) and half-maximum inhibition concentration 
(IC50, the value represents the concentration of ENR that produce 
50% inhibition of antibody binding to the hapten), and the maximal 
Amax/IC50 ratio was chosen (Hao et al., 2009). In our study, the 
concentrations of NaOH and methanol contents in the assay buffer 
have determinant effects on the standard inhibition curve, which 
was checked for the optimal data. 
 
 
Spiking tests in poultry samples 
 
Prior to running the assay, poultry samples (chicken and duck 
muscles) were homogenized, then 1 g of each meat sample was 
weighed into a 10 mL polypropylene centrifuge tube. Next 2 mL of 
0.1 mol/L sodium hydroxide-acetonitrile (1:10) was added, and the 
mixture was agitated on a shaker for 10 min. The samples were 
centrifuged at 5000 r/min for 10 min, and 1 mL of supernatants was 
diluted with 9 mL of PBS (0.01 mol/L ). 50 μL of this buffer solution 
was used in the ELISA. For spiking tests, a standard stock of ENR 
was prepared by diluting the initial solution prepared in HCl (0.03 
mol/L) to give a final stock solution at 1 mg/mL. The stock solution 
was serially diluted with PBS to give the working standard solutions. 
The recoveries were calculated by interpolation of the mean absor-
bance values on a standard curve constructed by icELISA in PBS. 
 
 




UV-vis spectrum for ENR-BSA, ENR, and BSA are 
presented in Figure 3. The absorbance for ENR-BSA 
(279 and 321 nm) gave a significant shifted peak at 279 
nm compared with the 269 nm peak for ENR (269, 321, 
and 333 nm), which indicated the ENR was successfully 
conjugated with BSA. The coating antigen of ENR-OVA 
gave a UV pattern similar to that of immunogen. 
Calculated from the formula, molar ratio of 18:1 for ENR-
BSA conjugates was obtained. 
 
 
Heterologous icELISA Standard curve 
 
Checkerboard titrations were performed, taking into 
account the optimal dilutions. The optimal reagent 
concentrations were determined when the maximum 
absorbances (Amax) were between 1.5 and 2.0, and the 
dose-response curve of inhibition ratio versus the ENR 
concentration pursued the lowest IC50 values. From the 
checkerboard assays, a representative standard inhibition 
curve was obtained (Figure 4). As can be seen, the 
optimum concentration of coating antigen was 1.0 μg/mL 
and pAb was 1:10,000 dilutions. This assay allowed the 
detection of ENR (20-80% inhibition of color 
development)  from  0.02 to 86.3 ng/mL, with an IC50  value
 
 



















































Figure 4. Optimized standard heterologous icELISA inhibition curve for ENR. Data were 
obtained by averaging three independent curves, each run in triplicate. ENR-OVA (1 μg/mL) 
as coating antigen was prepared in CBS (pH 9.6), purified anti-serum produced by ENR-
BSA as immunogen was diluted 1:10 000 in PBS (pH 7.4), ENR was prepared in PBS, 
containing 10% methanol; GaRIgG-HRP was diluted 1:1000 in incubation buffer. 
 
 





    2
    5
    10
    20
    30












































Figure 5. Effects of NaOH on the icELISA inhibition curve. Insets indicate the fluctuations of 
Amax/IC50 (Y-axis) as a function of NaOH concentration (X-axis). Each value represents the mean 









To study the influence of NaOH on the assay 
characteristics, competitive curves were prepared using 
standards in PBS which contained 2, 5, 10, 20, and 30% 
of NaOH. Figure 5 presents the effects of NaOH in assay 
solution on the ELISA. This result indicate that higher 
NaOH concentrations may change the ionization state of 
the antibody binding site, disrupt the ionic interactions, 
and resist the entrance of the standards. Accordingly, 5% 
NaOH in assay buffer provides the best conditions for the 
binding of antibody and coating antigen that was selected 
for the immunoassays. 
Methanol that may interfere with antigen-antibody 
binding and increase the solubility of analytes, was tested 
for its effects on the ELISA. Figure 6 shows the 
normalized dose-response curves at various solvent 
concentrations. The results show that the IC50 values of 
the immunoassay were varying obviously when increasing 
the amounts of methanol. It indicated that a reproducible 
inhibition curve could be observed, only when the 
concentration of the solvent was not higher than 30%. 
Therefore, to accurately determine the concentration of 






Specificity is a phenomenon inherent to all 
immunoassays, which was evaluated by determination of 
the cross-reactivity based on the IC50 values of individual 
chemicals. In this work, the study was undertaken by 
adding various competitors of functional related 
analogues. The cross-reactivity rate for each compound 
is presented in Table 1. Of all the cross-reacting 
analogues, this assay exhibited a high cross-reactivity to 




Correlations between concentrations spiked and 
determined in poultry samples 
 
The accuracy of the analysis was studied by comparative 
detection of fortified ENR in polutry muscle samples, and 
the measurement correlations between the fortified and 
analyzed concentrations are shown in Figure 7. We can 
find  that   the data  spots were nearly  distributed on both 
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Table 1. Cross-reactivities of FQs analogues in the ENR immunoassay. 
 
Analogue IC50 ( ng/mL ) CR (%) 
Enrofloxacin 0.8 100 
Ciprofloxacin 1.43 56 
Pefloxacin >1600 <0.05 
Danofloxacin >1600 <0.05 
Sarafloxacin >1600 <0.05 
Norfloxacin >1600 <0.05 
Lomefloxacin >8000 <0.01 
Ofloxacin >8000 <0.01 
Enoxacin >8000 <0.01 




sides of the trendline. This indicates that an excellent 
correlation between concentration spiked and 
concentration determined was found, and the results also 
suggest the veracity of the icELISA method for detecting 





We have prepared a high-quality polyclonal antibody  with 
high specificity for ENR. The feasibility to apply this 
antibody in a competitive ELISA has been explored, and 
the results show that this heterologous icELISA has been 
shown to be capable of detecting ENR residue in muscle, 
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y = 0.9343x + 0.1933 
R 2  = 0.9975 
y = 1.0086x + 0.04 
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Figure 7. Correlations between concentration spiked and concentration 





Abbreviations: ENR, Enrofloxacin; icELISA, indirect 
competitive enzyme linked immuno sorbent assay; pAb, 
polyclonal antibody; BSA, bovine serum albumin; OVA, 
ovalbumin; FCA, Freund's complete adjuvant; FIA, 
Freund's incomplete adjuvant; GaRIgG-HRP, the 
peroxidase-conjugated rabbit anti-mouse IgG; Amax, 
maximum absorbance; IC50, half-maximum inhibition 
concentration; LOD, limit of detection; CR, cross-reactivity; 
EDC, 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide; 
NHS, N-hydroxysuccinimide; FQs, fluoroquinolones; 
PBS, phosphate buffer saline; TMB, 3,3,5,5-
tetramethylbenzidine; HPLC, high performance liquid 
chromatography; LC-MS, liquid chromatography-mass 
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